Currently, existing literature focused on the diagnostic performance of PSMA PET and mpMRI in investigating the recurrence and metastasis of prostate cancer.10 11 Other studies have focused on the individual diagnostic performance of either PSMA PET or mpMRI.12 This evidence concerns the gene FOLH1 and prostate cancer.